Persistent T1 hypointensity as an MRI marker for treatment efficacy in multiple sclerosis

I.J. van den Elskamp, J. Lembcke, V. Dattola, K. Beckmann, C. Pohl, W. Hong, R. Sandbrink, K. Wagner, D.L. Knol, B.M.J. Uitdehaag, F. Barkhof

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)764-769
JournalMultiple Sclerosis
Volume14
Issue number6
DOIs
Publication statusPublished - 2008

Cite this

van den Elskamp, I. J., Lembcke, J., Dattola, V., Beckmann, K., Pohl, C., Hong, W., ... Barkhof, F. (2008). Persistent T1 hypointensity as an MRI marker for treatment efficacy in multiple sclerosis. Multiple Sclerosis, 14(6), 764-769. https://doi.org/10.1177/1352458507087842